Twist Bioscience Corporat... (TWST)
Twist Bioscience Corporation (TWST) Stock Price, Analysis & Data
| Bid | 88.2 |
| Market Cap | 7.75B |
| Revenue (ttm) | 431.8M |
| Net Income (ttm) | -136.72M |
| Beta | 2.16 |
| EPS (ttm) | -2.23 |
| PE Ratio (ttm) | n/a |
| Forward PE | -195.21 |
| P/B (ttm) | 17.38 |
| P/S (ttm) | 17.95 |
| Earnings Date | Nov 16, 2026 |
| Ask | 156.81 |
| Volume | 372,671 |
| Avg. Volume (20D) | 1,785,385 |
| Open | 124.00 |
| Previous Close | 123.12 |
| Day's Range | 120.94 - 124.00 |
| 52-Week Range | 23.30 - 125.66 |
| Analyst | Buy |
| Price Target | 115 (-6.98%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TWST
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mu...
Financial Performance
In 2025, Twist Bioscience's revenue was 376.57M, an increase of 20.32% compared to the previous year's 312.97M. Earnings were -77.67M, a decrease of -62.79%.
Financial StatementsAnalyst Forecast
According to 10 analyst ratings, the average rating for TWST stock is "Buy". The 12-month stock price forecast is 115, which is downside of 6.98% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
